- Facing Funding Losses, States Call Out Big Businesses With Employees on Medicaid
- Elevance Health's stock slides premarket even as it beats the Street with $1.5B in Q2 profit
- Physician pay drops, ACOs gain under CMS’ 2027 proposal: 8 things to know
- Insilico signs on with CDMO Bora in $2.5B AI drug discovery deal
- This psychiatric hospital CEO wants to retire the term ‘co-occurring’
- Physician assistant median pay hits $135K: State-by-state breakdown
- AI in the healthcare workforce: 4 notes
- CHOP increased naloxone co-prescribing from 3% to 84%: Study
- HCA now expects up to $1.2B hit from ACA headwinds
- Teladoc named preferred virtual care provider for NBA players union
- Automation Paid Off—So Why Are Denials Still Rising?
- 3 Russians indicted in $62M cybercrime scheme that hit hospitals
- CMS floats 1.68% cut to physician fee schedule, 7 other things to know
- Orthopedic robotics company lands up to $65M in growth capital
- 25 health systems dropping Medicare Advantage plans | 2026
- HCA names divisional CIO
- Minnesota system names interim CEO
- The America medical education system is not behaving as a normal market
- New York awards $6.3M for mental health clubhouses
- Smile Partners USA continues de novo strategy with new practice
- 988 crisis line tops 23M contacts since launch: 5 things to know
- Bipartisan Senate bill targets ASC Medicare reimbursement gap
- Outpatient care to grow 3x faster than inpatient: Report
- Average gross billings for owner dentists surpassed $1M in 2025
- CMS proposes major Medicare reforms to shift physician pay, phase out MIPS and expand ACO participation
- Specialty Dental Brands selects Videa as its AI platform
- States with the most, fewer psychologists per capita
- Oregon State Hospital named in wrongful death lawsuit
- Mobile care DSO Smile America Partners acquired by investment firm
- Judi Health rebrands PBM arm as Judi Rx, unveils Judi Care unit
- With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
- The specialties winning ASC procedure access — and losing on payment
- Anthropic pushes deeper into healthcare with Optum tie-up, UST integration
- FTC, CVS unveil settlement in ongoing insulin pricing case
- Are ASCs still the right investment? 3 orthopedic surgeons make the case
- What physicians miss when selling their ASC
- Why ASCs may not need a $1.5M spine robot
- North Carolina eye surgeon asks for reversal in CON trial
- HHS promises its final rule barring pediatric gender care providers from Medicare is still coming
- FDA issues psychedelic drug clinical trial guidance: 8 things to know
- Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
- AMA interoperability initiative brings structured clinical terminology to CPT codes
- Rising Tide Dental Partners expands network by 22%, appoints COO
- Lettuce Suspected In Growing Multistate Cyclospora Outbreak
- Startup Sonata launches preventive healthcare membership, linking clinical decisions with AI
- Why Are Family Doctors Leaving The Workforce? Retirement, Burnout Creating A U.S. Primary Care 'Brain Drain'
- HCA Healthcare now expects ACA exchange impacts to exceed $1B in 2026
- Huyabio scores with Opdivo combo in 'milestone' skin cancer trial
- Unruly Patients Are Stressing ER Staff, Undermining Care
- Pain Patients Should Taper Opioids At Their Own Pace, Study Suggests
- Heatwaves Raise Hospital Admissions For Mental Health Woes
- U.S. Gun Suicides Hit Record High, Even As Firearm Deaths Decline Overall
- AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal
- Worried About Your Aging Parents? Welcome To The Caregiving Club
- Lawmakers Look To Make Abortion Shield Laws Less Dependent on Who’s Governor
- Knee Pain? Ragged Cartilage? Research Suggests Surgery’s Not the Best Answer
- Real Chemistry builds body of AI healthcare commercialization tools with Anatomi launch
- Inside agency view: Havas SO on authenticity, connection and pushing back against the ‘sea of sameness’
- Why policy gaps threaten behavioral health coverage
- Specialty dentist pay vs. cost of living by state
- HHS, VA sign agreement to advance psychedelic therapy
- What the de novo boom means for DSOs
- Pearl vs. Videa vs. Overjet: what 3 AI giants have accomplished in 2026
- 8 dental Medicaid updates for dentists to know
- What DSO success looks like in the new age of dentistry
- Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
- Insulet, Calm join forces for diabetes care offerings with ‘Mind in Range’ wellness tools
- Hospital M&A stays hot in Q2 as health systems position for the future
- 13 behavioral health services, facility closures | 2026
- Cottage Health Expands Partnership with hellocare.ai Following Successful Pilot to Deploy AI Assisted Virtual Care and Patient Safety Platform Enterprise Wide
- North Carolina budget allocates millions for first-ever Rural Emergency Hospital reopening
- Payer-backed ad campaign urges lawmakers to reject NSA enforcement bill
- What Is An Aortic Dissection? The Condition That Killed Sen. Lindsey Graham
- Insurers set to pay out $759M in 2026 MLR rebates: KFF
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
- Germany pushes through healthcare reform package despite pharma's drug discount resistance
- GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- A New Option For Long-Term Care Costs
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
- Digital health funding hits $7.4B in 2026 as AI investment reshapes the market
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- Doctors want wearable data but healthcare isn't ready for it, AMA survey finds
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- A New Option for Long-Term Care Costs
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Remarks at the Society for Corporate Governance Conference
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Beyond Benchmarks: Why Trust Must Be Built into Clinical AI Infrastructure
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- How Lee Health Turned Language Access into a Strategic Clinical Asset
- Decision readiness is the next AI advantage
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Accountability Is Key to Medicaid's Home Care Future
- Clinical Success Is No Longer One Number
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- 9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- SCAN Health Plan, Alignment Healthcare sue to challenge CMS' MA star ratings recalculations
- Regulatory tracker: Eisai, Biogen scoop up subQ Leqembi starter dose nod
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
Michigan healthcare freedom community forum
Child deaths from marijuana ingestion increase after each state legalization. Packaging marijuana edibles like popular foot items sure doesn't help.
Commission demands firms immediately change unfair and deceptive packaging
July 5, 2023
As part of its ongoing monitoring of health-related advertising claims, the Federal Trade Commission today sent cease and desist letters – jointly with the U.S. Food and Drug Administration (FDA) – to six companies currently marketing edible products containing Delta-8 tetrahydrocannabinol (THC) in packaging that is almost identical to many snacks and candy children eat, including Doritos tortilla chips, Cheetos cheese-flavored snacks, and Nerds candy.
“Marketing edible THC products that can be easily mistaken by children for regular foods is reckless and illegal,” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “Companies must ensure that their products are marketed safely and responsibly, especially when it comes to protecting the well-being of children.”
“Children are more vulnerable than adults to the effects of THC, with many who have been sickened and even hospitalized after eating ‘edibles’ containing it. That’s why we’re issuing warnings to several companies selling copycat food products containing delta-8 THC, which can be easily mistaken for popular foods that are appealing to children and can make it easy for a young child to ingest in very high doses without realizing it,” said Janet Woodcock, M.D., Principal Deputy Commissioner, FDA.
The agencies sent letters to the following companies: 1) Delta Munchies LLC (Los Angeles, California); 2) Exclusive Hemp Farms (Gilroy, California) and Etienne-DuBois, LLC/Oshipt (Henrico, Virginia); 3) North Carolina Hemp Exchange, LLC, dba NC Hemp Shoppe (Raleigh, North Carolina; 4) Dr. Smoke, LLC, aka Dr. S, LLC (Kansas City, Missouri); 5) Nikte's Wholesale, LLC (Albuquerque, New Mexico); and 6) The Haunted Vapor Room (Franklin, New Jersey).
According to the letters, after reviewing online marketing for Delta-8 THC products sold by the six companies, the FTC has determined that their advertising may violate Section 5 of the FTC Act, which prohibits unfair or deceptive acts in or affecting commerce, including practices that present unwarranted health or safety risks. The letters stress that preventing practices that present such risks, particularly to children, is one of the Commission’s highest priorities, and that imitating non-THC-containing food products that children consume is misleading.
The companies’ Delta-8 THC products mimic a range of food that appeal to children. Dr. Smoke, LLC, for example, sells THC-infused “Doritos” that are marketed in packaging that is nearly the same as that of Doritos Nacho Cheese Flavored Tortilla Chips (see graphic), including using the same red background, the use of the Doritos name and triangle logo, and the depiction of two tortilla chips in the same position. In addition, Dr. Smoke’s THC-infused “Cheetos” are sold in packaging that is nearly identical to that of Cheetos Crunchy Flamin’ Hot Cheese Flavored Snacks, right down to the use of the Chester Cheetah mascot.
Another company, The Haunted Vapor Room, sells Delta-8 THC products called Rope 500mg Delta-8 Nerds Candy and Medicated Dope Rope Bites (see graphic) that closely resemble Nerds Rope candy, with both comprising multi-colored crunchy candies attached to a gummy rope, and packaging for the former using what appears to be the Nerds candy mascot.
A third company, Delta Munchies, LLC, markets Delta-8 THC gummies that look like conventional gummy candies that are often consumed by children (see graphic). The brightly colored packaging includes images of the products in fruity and sour flavors that the FTC contends enhance their appeal to children and increases the likelihood that they will mistakenly eat them, thinking they are traditional gummy candies.
In the letters, the FTC demands the companies stop marketing edible Delta-8 THC products that imitate conventional foods using advertising or packaging that is likely to appeal to young children. The FTC also strongly encourages the sellers to review all of their marketing and product packaging for similar edible THC products, and to take swift action and steps to protect consumers, especially young children, from these products.
Finally, the FTC has asked each company to contact agency staff within 15 days to detail the specific actions it has taken to address the Commission’s concerns. The primary staff attorney on this matter is Christine DeLorme in the FTC’s Bureau of Consumer Protection.
Colorful graphics for specific products are shown in article photos.
Published yesterday by the Annals of Internal Medicine, a response to one of the pre-legalization claims: that medical marijuana access would help chronic pain patients transition from standard pain medications.
The article is eligible for CME Point-of-Care and MOC credits.
Full research accessible from the summary page: https://doi.org/10.7326/M23-0053
Original Research | 4 July 2023By Emma E. McGinty, PhD, Kayla N. Tormohlen, PhD, Nicholas J. Seewald, PhD, Mark C. Bicket, MD, PhD, Alexander D. McCourt, JD, PhD, Lainie Rutkow, JD, PhD, Sarah A. White, MS, and Elizabeth A. Stuart, PhDEffects of U.S. State Medical Cannabis Laws on Treatment of Chronic Noncancer Pain
Abstract
Background:
State medical cannabis laws may lead patients with chronic noncancer pain to substitute cannabis in place of prescription opioid or clinical guideline–concordant nonopioid prescription pain medications or procedures.
Objective:
To assess effects of state medical cannabis laws on receipt of prescription opioids, nonopioid prescription pain medications, and procedures for chronic noncancer pain.
Design:
Using data from 12 states that implemented medical cannabis laws and 17 comparison states, augmented synthetic control analyses estimated laws’ effects on receipt of chronic noncancer pain treatment, relative to predicted treatment receipt in the absence of the law.
Setting:
United States, 2010 to 2022.
Participants:
583 820 commercially insured adults with chronic noncancer pain.
Measurements:
Proportion of patients receiving any opioid prescription, nonopioid prescription pain medication, or procedure for chronic noncancer pain; volume of each treatment type; and mean days’ supply and mean morphine milligram equivalents per day of prescribed opioids, per patient in a given month.
Results:
In a given month during the first 3 years of law implementation, medical cannabis laws led to an average difference of 0.05 percentage points (95% CI, −0.12 to 0.21 percentage points), 0.05 percentage points (CI, −0.13 to 0.23 percentage points), and −0.17 percentage points (CI, −0.42 to 0.08 percentage points) in the proportion of patients receiving any opioid prescription, any nonopioid prescription pain medication, or any chronic pain procedure, respectively, relative to what we predict would have happened in that month had the law not been implemented.
Limitations:
This study used a strong nonexperimental design but relies on untestable assumptions involving parallel counterfactual trends. Statistical power is limited by the finite number of states. Results may not generalize to noncommercially insured populations.
Conclusion:
This study did not identify important effects of medical cannabis laws on receipt of opioid or nonopioid pain treatment among patients with chronic noncancer pain.
Primary Funding Source:
National Institute on Drug Abuse.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























